LCTX - Lineage Cell Therapeutics GAAP EPS of -$0.04 in-line revenue of $1.44M beats by $0.08M
2024-05-09 16:22:10 ET
More on Lineage Cell Therapeutics
- Lineage Cell Therapeutics, Inc. (LCTX) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Lineage Cell Therapeutics
- Historical earnings data for Lineage Cell Therapeutics
- Financial information for Lineage Cell Therapeutics